Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
16.46
+0.04 (0.24%)
Nov 5, 2024, 11:05 AM EST - Market open
Evolus Employees
Evolus had 273 employees as of December 31, 2023. The number of employees increased by 58 or 26.98% compared to the previous year.
Employees
273
Change (1Y)
58
Growth (1Y)
26.98%
Revenue / Employee
$869,084
Profits / Employee
-$194,919
Market Cap
1.04B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| OPKO Health | 3,930 |
| Phreesia | 1,438 |
| agilon health | 1,117 |
| Maravai LifeSciences Holdings | 650 |
| Immatics | 535 |
| BioLife Solutions | 414 |
| Aurinia Pharmaceuticals | 300 |
| Collegium Pharmaceutical | 197 |
EOLS News
- 4 days ago - Evolus to Participate in Stifel 2024 Healthcare Conference - Business Wire
- 4 days ago - Evolus Announces EU Approval of Estyme® Injectable Hyaluronic Acid Gels Under New Medical Device Regulation - Business Wire
- 7 days ago - Evolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled Consumers - Business Wire
- 13 days ago - Evolus to Report Third Quarter Financial Results on November 6, 2024 - Business Wire
- 24 days ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024 - Business Wire
- 3 months ago - Evolus, Inc. (EOLS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Evolus reports first-ever adjusted profit in Q2 fueled by strong sales of Botox rival - Reuters